Ageing nuclear assets don't have to mean higher maintenance costs. Discover how HVTS® cladding helps extend the life of PWR secondary system components, reduce outage duration, support ALARA principles, and protect against FAC, erosion-corrosion and other degradation mechanisms. Learn more.

November 18, 2024, 9:30AMNuclear News

Bernard Fontana (left) of Framatome and Cosmin Ghiță of Nuclearelectrica. (Photo: Framatome)

Framatome and SN Nuclearelectrica, a partially state-owned Romanian nuclear energy company, have entered into a long-term cooperation agreement to produce the medical isotope lutetium-177 at Cernavoda nuclear power plant in Romania. Lu-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of neuroendocrine tumors and prostate cancer.

To continue reading, log in or create a free account!

Droughts, wildfires continue to impact power plants in Europe

August 3, 2026, 3:45PMNuclear News

The effects of this summer’s historic heatwave continue to be felt across Europe. Soaring temperatures and drought in the region have led to elevated river temperatures, low river levels,...

Ontario invests in medical radioisotope production at McMaster

August 6, 2026, 7:03AMNuclear News

With a new investment of C$4.6 million (approximately $3.3 million) from the government of Ontario, Canada, operations of the McMaster Nuclear Reactor (MNR) at McMaster University are being...

DOE issues RFI for reuse of SRS heavy water

August 4, 2026, 9:24AMNuclear News

The Department of Energy’s Office of Environmental Management has issued a request for information for industry input about the best ways to reuse and repurpose as much as 530,000 gallons of...

Nuclear developments in France, Germany, the Czech Republic, and beyond

July 27, 2026, 9:29AMNuclear News

Recent happenings in Europe highlight that nuclear power activities are expanding globally. Here is a roundup of headlines with an international flavor....

Reimagining nuclear materials for the future of medicine

May 22, 2026, 3:07PMNuclear NewsTim Tinsley and Katie Baverstock-Hunt

Nuclear medicine has come a long way since Henri Becquerel first observed the penetrating energy of radioactive materials in 1896. Today, technetium-99m alone is used in more than 40 million...

DOE, PNNL, and Commerce Dept. collaborate on Ra-226 recovery

May 22, 2026, 7:04AMNuclear News

A collaboration between the Department of Energy’s Office of Isotope R&D and Production and the Department of Commerce’s National Institute of Standards and Technology has recovered...

Canada funds fusion-based copper-67 production project

May 20, 2026, 12:42PMNuclear News

The Canadian Medical Isotope Ecosystem, which is backed by the Canadian federal government’s Strategic Innovation Fund, has announced funding for a collaboration between Promation, Astral...

Framatome licensed to produce LEU+ fuel at its Richland plant

May 8, 2026, 2:30PMNuclear News

Framatome announced this week that its nuclear fuel manufacturing facility in Richland, Wash., has received Nuclear Regulatory Commission approval for a license amendment supporting...

TerraPower announces second Ac-225 production facility

March 19, 2026, 9:27AMNuclear News

TerraPower Isotopes, a TerraPower subsidiary, plans to increase its actinium-225 production 20-fold by opening a new manufacturing facility in Philadelphia, Pa., and by expanding the capacity...

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

Framatome to produce Lu-177 at Romania’s Cernavoda

Related Articles